This site is intended for US Health Care Professionals only.
The recombinant antigen used to make PROVENGE is PAP-GM-CSF. It consists of prostatic acid phosphatase (PAP), an antigen expressed in more than 95% of prostate cancers, and granulocyte-macrophage colony-stimulating factor (GM-CSF), an immune-cell activator.1
©2017 Valeant Pharmaceuticals North America LLC. PRV.0032.USA.17